Core Insights - The surgical robot market is highly competitive but not saturated, with significant growth potential in China [2] - Johnson & Johnson is accelerating its investment in the surgical robot sector in China, particularly through partnerships with local companies [2][7] - The Haishan I, developed by Chinese company RuLong Surgical, is a notable product showcased by Johnson & Johnson, representing a strategic collaboration [2][3] Market Dynamics - The surgical robot market is characterized by intense competition, with Intuitive Surgical's Da Vinci system holding a dominant market share of 53.8% as of Q2 2025 [3] - RuLong Surgical's Haishan I is the first modular surgical robot in China, offering flexibility and lower production costs compared to traditional integrated systems [3][4] - Johnson & Johnson's entry into the surgical robot market has been relatively late, but the company has made several acquisitions and is optimistic about future growth [4][5] Product Development - Johnson & Johnson currently has one approved surgical robot in China, the MONARCH, while aiming for a target installation of 500 units for the Haishan I within five years [4][5] - The Haishan I has received approvals for multiple surgical applications, unlike many competitors that require separate approvals for each application [3][4] Pricing and Cost Structure - The high cost of surgical robots has historically limited their adoption, with prices for leading models exceeding 20 million yuan [5][6] - Johnson & Johnson is focused on optimizing technology and supply chains to reduce costs and improve competitiveness in the market [6] Collaboration and Commercialization - Johnson & Johnson has engaged in several collaborations with local medical device companies to enhance commercialization efforts [7] - The company is also exploring international markets for its products, contingent on confirming quality and supply chain stability [8] Market Opportunities - The aging population in China presents a significant opportunity for the medical device market, driving demand for surgical interventions [8] - Johnson & Johnson showcased over 1,000 products at the China International Import Expo, indicating a strong commitment to integrating into China's innovation ecosystem [8]